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Edited by Pascale CossartAbstract In the present paper, we report the biochemical char-
acterization of a chromosomal toxin–antitoxin (TA) system in
Mycobacterium tuberculosis, consisting of the Rv1991c gene
and its upstream open reading frame (ORF) termed Rv1991a.
Rv1991c was characterized as a toxin with ribonuclease activity
and Rv1991a as the antitoxin against Rv1991c. Rv1991a
interacted with Rv1991c to form a complex. A promoter located
immediately upstream of Rv1991a was identiﬁed. Both Rv1991a
and the Rv1991a–Rv1991c complex were able to bind to the
promoter region of the Rv1991a–Rv1991c operon, indicating
that the expression of the Rv1991a–Rv1991c operon can be auto-
regulated.
 2008 Federation of European Biochemical Societies.
Published by Elsevier B.V. All rights reserved.
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tuberculosis1. Introduction
A typical toxin–antitoxin (TA) system consists of two genes,
one for a stable toxin and the other for an unstable antitoxin.
The toxin and antitoxin interact with each other to form a
complex. Both the antitoxin–toxin complex and the antitoxin
alone can bind to promoter region to autoregulate the expres-
sion of TA system at transcription level. TA systems, which
were originally identiﬁed on plasmids, have been detected on
chromosomes of numerous bacteria, and the chromosomal
TA systems are proposed to be involved in the bacterial cell
growth control or bacterial programmed cell death under the
stress conditions [1–3].
Up to one-third of humansworldwide infected byMycobacte-
rium tuberculosis are in a latent state and at risk for tuberculosis
when immune-compromised [4,5]. The latency of tuberculosis
infections is attributed to the ability ofM. tuberculosis to persist
at a non-replicating state in a host lesion under the stress condi-
tion with reduced availability of nutrients and oxygen [6,7]. By
sequence homology, 38 toxin–antitoxin systems have been iden-
tiﬁed inM. tuberculosisH37Rv and 36 systems inM. tuberculo-Abbreviations: TA, toxin–antitoxin; ORF, open reading frame; IPTG,
isopropyl b-D-thiogalactopyranoside; MCS, multi-cloning site; EMSA,
electrophoretic mobility shift assay
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doi:10.1016/j.febslet.2008.01.045sis CDC1551 [1]. We have reported that seven M. tuberculosis
genes encode the proteins homologous to MazF, the toxin in
Escherichia coli mazEF TA system. Four of the MazF homo-
logues, Rv2801, Rv1991c, Rv0659c and Rv1102c, were identi-
ﬁed as toxins, among which Rv2801c and Rv1102c were
characterized as ribonucleases cleaving RNA in a sequence-spe-
ciﬁc manner [8]. An open reading frame (ORF) locates immedi-
ately upstream of Rv199c and overlaps with Rv1991c by 7 base
pairs. Recently Rv1991c and its upstream ORF have been pro-
posed to form a putative toxin–antitoxin pair [9], but the bio-
chemical properties and molecular mechanism of such a TA
system remain unknown. In this work, we characterized
Rv1991c as a toxin with ribonuclease activity. The ORF located
upstream of Rv199c, termed as Rv1991a, encoded the antitoxin
Rv1991a, which inhibited the ribonuclease activity of Rv1991c
by forming Rv1991a–Rv1991c complex. Both Rv1991a–
Rv1991c complexes and Rv1991a alone could bind to the
promoter region of Rv1991a–Rv1991c operon. These data indi-
cate that theRv1991a–Rv1991c operon is a typical TA systemon
M. tuberculosis chromosome.2. Materials and methods
2.1. Strains and media
Mycobacterium smegmatis mc2155 was grown in Middlebrook 7H9
medium with 0.2% glycerol and 0.05% Tween 80 or on Middlebrook
7H10 agar medium with 0.5% glycerol, supplemented with OADC
(Difco). All E. coli strains were grown in M9 or LB medium. Hygro-
mycin was added as required at a concentration of 150 mg/L for
E. coli and 50 mg/L for mycobacteria. Kanamycin was added as re-
quired at a concentration of 50 mg/L for E. coli and 25 mg/L for myco-
bacteria.
2.2. Construction of vectors
M. tuberculosis Rv1991c gene was cloned into the NdeI-XhoI sites
of pET28a, creating pET28a-(His)6Rv1991c for expression of
(His)6Rv1991c in E. coli. The Rv1991a ORF was cloned into the
NdeI-XhoI sites of pET28a, creating pET28a-(His)6Rv1991a for
expression of (His)6Rv1991a in E. coli. Expression vector pACYCD-
uet (Novage) has two multi-cloning sites (MCS). The Rv1991c gene
was cloned into MCS II of pACYCDuet, creating pACYC-1991c.
The Rv1991a ORF was cloned into MCS I of pACYC-1991c, creating
pACYC-1991a–1991c. The Rv1991a ORF was cloned into the
BamHI–HindIII sites of pMV261, creating pMV261-Rv1991a. The
Rv1991c gene was cloned into the BamHI-ClaI sites of pACE,
creating pACE-Rv1991c for inducible expression of Rv1991c in
M. smegmatis. The M. tuberculosis Rv0707 gene was cloned into the
BamHI-HindIII sites of pET17b, creating pET17b-Rv0707. The 99
base pair sequence located upstream of Rv1991a was cloned into
the XbaI-SphI sites ahead of the promoterless lacZ gene in pSD5B
[10], creating pSD5B-99bp.blished by Elsevier B.V. All rights reserved.
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(His)6Rv1991a and (His)6Rv1991c were mixed in binding buﬀer
(50 mM Tris–HCl, pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, and
5% glycerol) at 4 C for 30 min. The compositions of the stacking
gel and the separation gel are same as described previously [11]. Elec-
trophoresis was performed at constant voltage (150 V) at 4 C. Tricine
SDS–PAGE was carried out for the resolution of low molecular mass
proteins as described previously [11].
2.4. In vitro RNA cleavage by Rv1991c
The DNA fragment containing a T7 promoter followed by the M.
tuberculosis Rv0707 gene was obtained by PCR ampliﬁcation with the
T7 primer 5 0-AGATCTCGATCCCGCAAATTAAT-30 and the primer
Rv0707-2 5 0-TCAGCTCTCCGTGCTCTG-3 0 with pET17b-Rv0707
plasmid as template. Another DNA fragment containing a T7 promoter
followed by the E. coli era gene was obtained by PCR ampliﬁcation
with the T7 primer 5 0-AGATCTCGATCCCGCAAATTAAT-30 and
the primer era-2 5 0-TTAAAGATCGTCAACGTAACCG-3 0 with
pET28a-Era plasmid [12] as template. The Rv0707 mRNA and era
mRNA were prepared from these two DNA fragments respectively
with the RiboMAX T7 large scale RNA production system (Prome-
ga). RNA substrates were incubated with (His)6Rv1991c at 37 C for
15 min. Each reaction mixture (10 ll) contained 1.5 lg of RNA
substrate, 100 pmol (His)6Rv1991c, 1 ll of RNase inhibitor, 20 mM
Tris–HCl (pH 8.0), 100 mM NaCl, and 1 mM DTT. The reaction
mixture was then subjected to 5% PAGE.0
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Fig. 1. Toxic eﬀect of Rv1991c and antitoxic eﬀect of Rv1991a. (A) Plasmids
E. coli BL21(DE3) strains harboring diﬀerent plasmids were grown on M
M. smegmatis mc2155 cells harboring the plasmids as indicated were grown in
acetamide (II). Control (h),M. smegmatis harboring pACE and pMV261; TA
T (m), M. smegmatis harboring pACE-Rv1991c and pMV261.2.5. Determination of promoter activity
Promoter activity was determined by b-galactosidase activity assays.
Assays for b-galactosidase activity were performed as described by
Miller [13].
2.6. Electrophoretic mobility shift assays (EMSA)
The DNA fragment consisting of the 99 base pairs located upstream
of Rv1991a was 5 0 end-labeled with [c-32P]-ATP and T4 polynucleotide
kinase. The binding reactions were carried out at 4 C for 30 min with
puriﬁed proteins and [32P]-labeled 99-bp DNA in the binding buﬀer
(50 mM Tris–HCl, pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 5%
glycerol and 10 lg/ml poly(dI-dC)). Electrophoresis was performed
with 8% native polyacrylamide gel in TAE buﬀer.3. Results and discussion
3.1. Characterization of toxin Rv1991c and antitoxin Rv1991a
The eﬀects of Rv1991c and Rv1991a on bacterial cell were
tested in E. coli and M. smegmatis. The pACYCDuet-1 vector
has two multi-cloning sites (MCS), each of which is under an
isopropyl b-D-thiogalactopyranoside (IPTG)-inducible pro-
moter. In the presence of IPTG, E. coli cells harboring
pACYC- 1991c with Rv1991c at MCS II could not grow on1 2 3 4 5 6 7 8 9 10 11 12 13
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were transformed into E. coli BL21(DE3) as indicated in each sector (I).
9 plates without IPTG (II) or with 0.1 mM IPTG (III). (B) The
7H9 middlebrook medium (Difco) without acetamide (I) or with 0.2%
(n),M. smegmatis harboring pACE-Rv1991c and pMV261-Rv1991a;
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1991c with Rv1991a at MCS I and Rv1991c at MCS II were
able to grow (Fig. 1A). To assess the toxic eﬀect of Rv1991c
on mycobacteria cell, the Rv1991c gene was cloned under the
inducible acetamidase promoter in pACE, an E. coli–M.
smegmatis shuttle vector. When M. smegmatis cells harboring
pACE-Rv1991c were cultured in the presence of acetamide,
the cell growth was signiﬁcantly arrested. The growth inhibi-
tion was released when pMV261-Rv1991a with Rv1991a under
the hsp60 promoter was introduced into M. smegmatis cells
harboring pACE-Rv1991c (Fig. 1B), indicating that the simul-
taneous expression of Rv1991a prevents the toxicity of
Rv1991c. These results suggest that Rv1991c is toxic to bacte-
rial cell, while Rv1991a functions as an antitoxin against
Rv1991c.
3.2. Rv1991c and Rv1991a form a complex
(His)6Rv1991a and (His)6Rv1991c were expressed in E. coli
BL21(DE3) and puriﬁed by aﬃnity chromatography.
(His)6Rv1991a and (His)6Rv1991c are referred as Rv1991a
and Rv1991c in the following in vitro experiments. When
the puriﬁed Rv1991a and Rv1991c were subjected to native
PAGE respectively, Rv1991a was found as a band at the
bottom of the gel (Fig. 2A, lane 2), while Rv1991c could
not be detected (Fig. 2A, lane 1). It may be due to the highly
positive charge of Rv1991c, which keeps Rv1991c from run-
ning into the gel under the experimental condition. When the
mixture of Rv1991a and Rv1991c was subjected to native
PAGE, a new band appeared at the position near the top
of the gel (Fig. 2A, lanes 3 and 4). The gel corresponding
to the new band was cut out, and then put on the top of
Tricine SDS–PAGE gel to run a second dimensional electro-
phoresis to analyze the protein components. Two bands cor-
responding to Rv1991c and Rv1991a were observed (Fig. 2B,
lanes 3 and 4). These data demonstrate that Rv1991a canR
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Fig. 2. Rv1991a–Rv1991c complex formation. (A) Native PAGE. Lane 1,
mixture of (His)6Rv1991a and (His)6Rv1991c with diﬀerent molar ratios as in
SDS–PAGE. The gel corresponding to the band of the complex was cut o
components. Lane M, protein molecular mass markers; lane 1, (His)6Rv1991
lane 4, the complex from lane 4 of panel A.interact with Rv1991c to form a stable complex. As shown
in Fig. 2A, Rv1991a was totally recruited to form the com-
plex when the molar ratio of Rv1991a to Rv1991c was 1:2.
Although the exact composition of Rv1991a–Rv1991c com-
plex is still unknown, it is possible that, as same as the molar
ratio of MazE to MazF in MazE-MazF complex, the molar
ratio of Rv1991a to Rv1991c is 1:2 in Rv1991a–Rv1991c
complex.
3.3. Rv1991c has the ribonuclease activity
Rv1991c has the sequence similarity with Rv2801c, Rv1102c
and E. coli MazF. In respect that Rv2801c, Rv1102c and
MazF have been characterized as ribonucleases, the RNA
cleavage activity of Rv1991c was tested. When E. coli era
mRNA was used as substrate, the RNA was digested after
incubated with Rv1991c (Fig. 3A, lane 3). Rv1991a inhibited
the RNA cleavage activity of Rv1991c in a dose-dependent
manner (Fig. 3A, lanes 4 and 5). The ribonuclease activity of
Rv1991c was almost totally inhibited when the molar ratio
of Rv1991a to Rv1991c was increased to 1:2 (Fig. 3A, lane
5), supporting the hypothesis that the molar ratio of
Rv1991a to Rv1991c in Rv1991a–Rv1991c complex is about
1:2. M. tuberculosis is a pathogen with high GC content in
its genome. It is interesting to test the ribonuclease activity
of Rv1991c against M. tuberculosis mRNAs. As same as the
era mRNA, the mRNA of M. tuberculosis Rv0707 gene (GC
67.4%) was digested by Rv1991c, and protected by Rv1991a
in a dose-dependent manner (Fig. 3B). Same results were ob-
served when the mRNA of M. tuberculosis Rv0527 gene (GC
69.2%) and the total RNA from M. tuberculosis H37Rv were
used as substrates (data not shown). These data indicate that
Rv1991c is a toxic ribonuclease arresting bacterial cell growth
through the mechanism of RNA cleavage, and that Rv1991a
inhibits the ribonuclease activity of Rv1991c by forming
Rv1991a–Rv1991c complex.M      1      2      3      4  (kDa)
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Fig. 3. Ribonuclease activity of Rv1991c. (A) E. coli era mRNA was used as substrate; (B) M. tuberculosis Rv0707 mRNA was used as substrate.
Each reaction was performed at 37 C for 15 min with 1.5 lg RNA. The reaction products were analyzed by 5% PAGE. Lane 1, control, RNA alone;
lane 2, RNA incubated with 50 pmol (His)6Rv1991a; lane 3, RNA incubated with 100 pmol (His)6Rv1991c; lanes 4 and 5, RNA incubated with
100 pmol (His)6Rv1991c together with 25 pmol and 50 pmol (His)6Rv1991a, respectively.
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Fig. 4. Binding abilities of Rv1991a and Rv1991a–Rv1991c complex to the promoter DNA. (A) Analysis of the promoter activity. M. smegmatis
mc2155 cells containing pSD5B (I) or pSD5B-99bp (II) were grown in 7H9 Middlebrook medium with 2.0% glucose till mid-log phase before harvest.
The b-galactosidase activity assays were done in triplicates, and the data represent the averages. (B–D) Binding abilities of Rv1991a (B), Rv1991a
mutants (C) and Rv1991a–Rv1991c complex (D) to the promoter DNA were determined by EMSA as described in Section 2.
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alone can bind to the promoter region
The 99 base pair sequence located immediately upstream of
Rv1991a was cloned ahead of the promoterless lacZ gene in
pSD5B vector to construct the promoter-reporter plasmid
pSD5B-99bp, which was transformed into M. smegmatis for
promoter activity determination by b-galactosidase assays.
As shown in Fig. 4A, the promoter activity was detected from
the 99-bp DNA fragment. In the updated annotation of M.
tuberculosis H37Rv genome, Rv1991a has not been identiﬁed
as an ORF. The existence of a promoter upstream of
Rv1991a suggests that Rv1991a is an active ORF to form the
Rv1991a–Rv1991c operon.
The DNA fragment consisting of the 99 base pairs located
upstream of Rv1991a was 5 0 end-labeled with [c-32P]-ATP and
T4 polynucleotide kinase, and then used to test the promoter
binding abilities of Rv1991a, Rv1991c and Rv1991a–Rv1991c
complex by EMSA. The antitoxin Rv1991a could bind to the
DNA fragment and shift it up (Fig. 4B), while the toxin
Rv1991c could not (data not shown). Several substitutionmuta-
tions weremade in theN-terminal region ofRv1991a. The S25A
and R26A mutation disrupted the DNA binding ability of
Rv1991a (Fig. 4C, lanes 4 and 5), suggesting that theN-terminal
region of Rv1991a is involved in DNA binding. The Rv1991a–
Rv1991c complex was also able to bind to the 99-bp DNA frag-
ment. Compared with Rv1991a alone, the Rv1991a–Rv1991c
complex has signiﬁcant higher binding aﬃnity to the promoter
region of Rv1991a–Rv1991c operon (Fig. 4D). These data indi-
cate that the expression of Rv1991a–Rv1991c system can be
autoregulated at transcription level.
Most M. tuberculosis infections do not immediately develop
into acute diseases. The host immune response restricts the
development of active infection by quarantining M. tuberculo-
sis in granuloma, while the M. tuberculosis bacterium can per-
sist in granulomatous lesions in a non-replicative state, with
the ability to resume growth and activate disease [14]. It has
been demonstrated that the stress conditions such as nutrient
deprivation and oxygen limitation play a role in inducing
non-replicacing persistence [15]. Under normal growth condi-
tions, the antitoxin and toxin are coexpressed from a TA oper-
on and form a stable complex. However, the stresses may aﬀect
the balance between toxin and antitoxin and release the free
toxin, allowing cells to enter a persistent state. We have char-
acterized the Rv1991a–Rv1991c operon as a TA system on M.
tuberculosis chromosome, encoding antitoxin Rv1991a and
toxin Rv1991c with ribonuclease activity, but we do not pres-
ently know which stringent regulator can activate the toxicity
of endogenous Rv1991c. Further works will be done to inves-
tigate the expression control of Rv1991a–Rv1991c TA system
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